Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-26-003926
Filing Date
2026-06-05
Accepted
2026-06-05 06:05:06
Documents
2
Period of Report
2026-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_060526.htm 6-K 8466
2 PRESS RELEASE exh_991.htm EX-99.1 7686
  Complete submission text file 0001171843-26-003926.txt   17165
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39179 | Film No.: 261066774
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)